Erica Mann

Erica joined the Board in September 2021. Erica has over 30 years of experience in roles of increasing responsibility across the healthcare industry and more than 25 years of active P&L management. Erica most recently served as President & Head of Bayer’s Global Consumer Health Division where she directed every aspect of one of the world’s leading global consumer selfcare companies. Prior to joining Bayer, Erica was the Global President and General Manager of Pfizer (Wyeth) Nutrition.

Erica has worked in highly regulated, complex multi-channel and multi product environments across multiple jurisdictions. She has significant experience in both small- & large-scale health related M&A and integration. She has deep expertise in extracting strategy from health trends with a strong focus on culture, risk management and ESG.

Erica has a strong understanding of complementary medicines and naturopathic principles and deep experience in over-the-counter therapeutic goods. She chaired the board of the World Self-Medication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements, and held executive positions on the boards of South African Pharmaceutical Manufacturers’ Association, Medicines Australia and International Association of Infant Food Manufacturers.

Erica currently serves as a Non-Executive Director of Kellogg Company (NYSE: K), Perrigo Company PLC (NYSE: PRGO) and Supervisory Board Member at Koninklijke DSM N.V (AMS: DSM). She recently completed Berkeley Law School’s ESG certificate course. Fortune named Erica to the list of the 50 Most Powerful Women International in 2016 and 2017. Erica was also selected by Nelson Mandela to participate in the Trade Mission to the UK in 1996.

Erica is based in Sydney, Australia.